On July 4, American taxpayers are set to resume funding one of the nation’s largest providers of so-called gender-affirming care for children, which also just happens to be the nation’s largest provider of abortion. If that’s not a killjoy for America’s 250th birthday, I don’t know what is.
Last year, President Donald Trump’s One Big Beautiful Bill Act defunded Big Abortion providers like Planned Parenthood of almost $800 million in taxpayer-funded Medicaid reimbursements, dealing a significant blow to the nation’s largest abortion franchise.
In July 2025 alone, Planned Parenthood shuttered 25 clinics across the country, and the total number of closures has reached 47. Planned Parenthood cannot seem to survive on its own without a $792.2 million crutch from hard-working Americans who, by and large, do not want to be complicit in its practices.
While the one-year defunding of Big Abortion businesses in the “One Big, Beautiful Bill” demonstrated one of the largest legislative wins in pro-life history, the defunding is set to expire on July 4, 2026. Come America’s 250th, taxpayers will be footing the bill for the nation’s largest abortion franchise once again.
Little do many realize, however, that funding Planned Parenthood also means propping up one of the nation’s leading providers of so-called gender-affirming care: cross-sex hormones, puberty blockers, and referrals for mastectomies and other sex-rejecting procedures.
Read the full op-ed at The Daily Signal.
